Skip to main content

Peer Review reports

From: Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway

Original Submission
3 Aug 2023 Submitted Original manuscript
22 Sep 2023 Reviewed Reviewer Report
25 Sep 2023 Reviewed Reviewer Report - Faruck Lukmanul Hakkim
3 Feb 2024 Author responded Author comments - Yiguo Cao
Resubmission - Version 2
3 Feb 2024 Submitted Manuscript version 2
7 Mar 2024 Author responded Author comments - Yiguo Cao
Resubmission - Version 3
7 Mar 2024 Submitted Manuscript version 3
18 Mar 2024 Reviewed Reviewer Report - Faruck Lukmanul Hakkim
20 Mar 2024 Author responded Author comments - Yiguo Cao
Resubmission - Version 4
20 Mar 2024 Submitted Manuscript version 4
21 Mar 2024 Author responded Author comments - Yiguo Cao
Resubmission - Version 5
21 Mar 2024 Submitted Manuscript version 5
Publishing
22 Mar 2024 Editorially accepted
15 Apr 2024 Article published 10.1186/s12885-024-12167-z

You can find further information about peer review here.

Back to article page